These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 3371266)
41. The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength--assessed in a sexually mature, ovariectomized rat model. Mosekilde L; Danielsen CC; Søgaard CH; McOsker JE; Wronski TJ Bone; 1995 Feb; 16(2):223-30. PubMed ID: 7756051 [TBL] [Abstract][Full Text] [Related]
42. Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. Gunness-Hey M; Hock JM Metab Bone Dis Relat Res; 1984; 5(4):177-81. PubMed ID: 6738355 [TBL] [Abstract][Full Text] [Related]
43. Stimulation of femoral trabecular bone growth in ovariectomized rats by human parathyroid hormone (hPTH)-(1-30)NH(2). Whitfield JF; Morley P; Willick GE; MacLean S; Ross V; Barbier J; Isaacs RJ Calcif Tissue Int; 1999 Aug; 65(2):143-7. PubMed ID: 10430648 [TBL] [Abstract][Full Text] [Related]
44. Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats. McManus JF; Davey RA; Maclean HE; Doust EA; Chiu WS; Sims NA; Bouxsein ML; Glatt V; Zajac JD; Danks JA Bone; 2008 Jun; 42(6):1164-74. PubMed ID: 18387351 [TBL] [Abstract][Full Text] [Related]
45. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats. Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872 [TBL] [Abstract][Full Text] [Related]
46. Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum. Oxlund H; Ejersted C; Andreassen TT; Tørring O; Nilsson MH Calcif Tissue Int; 1993 Dec; 53(6):394-9. PubMed ID: 8293353 [TBL] [Abstract][Full Text] [Related]
47. Maintenance of bone mass by physical exercise after discontinuation of intermittent hPTH(1-34) administration. Yamamoto N; Takahashi HE; Tanizawa T; Fujimoto R; Hara T; Tanaka S Bone Miner; 1993 Dec; 23(3):333-42. PubMed ID: 8148673 [TBL] [Abstract][Full Text] [Related]
48. Effect of human parathyroid hormone (PTH(1-34)) on experimental osteopenia of rats induced by ovariectomy. Hori M; Uzawa T; Morita K; Noda T; Takahashi H; Inoue J Bone Miner; 1988 Jan; 3(3):193-9. PubMed ID: 3207944 [TBL] [Abstract][Full Text] [Related]
49. The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84). Mosekilde L; Søgaard CH; Danielsen CC; Tørring O Endocrinology; 1991 Jul; 129(1):421-8. PubMed ID: 2055197 [TBL] [Abstract][Full Text] [Related]
50. [Effects of teriparatide and alendronate on bone mineral density of osteoporotic rats]. Li M; Jiao J; Meng XW; Xing XP; Xia WB; Zhou XY; Liu HC; Jiang Y; Wang O; Hu YY; Zhan ZW Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):335-8. PubMed ID: 15854512 [TBL] [Abstract][Full Text] [Related]
51. Influence of ovariectomy and estradiol treatment on calcium homeostasis during aging in rats. Gaumet N; Seibel MJ; Coxam V; Davicco MJ; Lebecque P; Barlet JP Arch Physiol Biochem; 1997 Sep; 105(5):435-44. PubMed ID: 9439780 [TBL] [Abstract][Full Text] [Related]
52. Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys. Brommage R; Hotchkiss CE; Lees CJ; Stancill MW; Hock JM; Jerome CP J Clin Endocrinol Metab; 1999 Oct; 84(10):3757-63. PubMed ID: 10523026 [TBL] [Abstract][Full Text] [Related]
53. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength. Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596 [TBL] [Abstract][Full Text] [Related]
54. A comparison of the effects of two anabolic agents (fluoride and PTH) on ash density and bone strength assessed in an osteopenic rat model. Søgaard CH; Mosekilde L; Thomsen JS; Richards A; McOsker JE Bone; 1997 May; 20(5):439-49. PubMed ID: 9145241 [TBL] [Abstract][Full Text] [Related]
55. Stimulation of the growth of femoral trabecular bone in ovariectomized rats by the novel parathyroid hormone fragment, hPTH-(1-31)NH2 (Ostabolin). Whitfield JF; Morley P; Willick GE; Ross V; Barbier JR; Isaacs RJ; Ohannessian-Barry L Calcif Tissue Int; 1996 Feb; 58(2):81-7. PubMed ID: 8998682 [TBL] [Abstract][Full Text] [Related]
56. Evidence for a prospective anti-osteoporosis effect of black tea (Camellia Sinensis) extract in a bilaterally ovariectomized rat model. Das AS; Mukherjee M; Mitra C Asia Pac J Clin Nutr; 2004; 13(2):210-6. PubMed ID: 15228990 [TBL] [Abstract][Full Text] [Related]
57. Response of femoral neck to estrogen depletion and parathyroid hormone in aged rats. Li M; Wronski TJ Bone; 1995 May; 16(5):551-7. PubMed ID: 7544601 [TBL] [Abstract][Full Text] [Related]
58. Early effects of short-term parathyroid hormone administration on bone mass, mineral content, and strength in female rats. Toromanoff A; Ammann P; Riond JL Bone; 1998 Mar; 22(3):217-23. PubMed ID: 9514214 [TBL] [Abstract][Full Text] [Related]
59. Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys. Burr DB; Hirano T; Turner CH; Hotchkiss C; Brommage R; Hock JM J Bone Miner Res; 2001 Jan; 16(1):157-65. PubMed ID: 11149480 [TBL] [Abstract][Full Text] [Related]
60. Combined treatment with PTH (1-34) and OPG increases bone volume and uniformity of mineralization in aged ovariectomized rats. Valenta A; Roschger P; Fratzl-Zelman N; Kostenuik PJ; Dunstan CR; Fratzl P; Klaushofer K Bone; 2005 Jul; 37(1):87-95. PubMed ID: 15869920 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]